| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | −30.8× | −1.7× | |
| Price / Book | 10.1× | 2.0× | |
| Price / Sales | 44.8× | 3.9× | |
| Price / Free cash flow | −42.1× | −1.6× | |
| EV / EBITDA | −33.8× | −1.1× | |
| Earnings yield | −3.2% | −14.6% | |
| Free cash flow yield | −2.4% | −9.9% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,257.03 | +0.43% | $1.18T | 57.3× | 77.8% | +16.7% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $255.56 | +0.90% | $615.87B | 23.0× | 32.9% | +33.7% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $285.42 | +0.71% | $504.37B | 119.3× | −129.2% | +26.2% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $401.43 | −1.29% | $360.32B | 29.9× | 12.8% | +11.2% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $145.95 | +0.52% | $360.08B | 19.7× | 34.7% | +73.5% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $150.62 | +0.16% | $278.63B | 19.8× | 30.5% | +15.9% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $165.41 | −0.76% | $256.54B | 25.0× | 21.1% | −2.2% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $690.00 | −0.93% | $255.13B | 37.9× | 12.6% | +30.7% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $432.49 | −0.35% | $233.82B | 30.3× | 89.1% | +45.5% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $156.19 | −0.75% | $193.67B | 22.8× | 37.5% | +32.0% |
